Caldera Medical, a leader in the development of implants for the treatment of female Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP), has announced it will highlight three of its newest FDA cleared solutions for SUI and POP at the American Association of Gynecologic Laparoscopists (AAGL) 42nd Global Congress On Minimally Invasive Gynecology running from November 10th through November 14th in Washington DC. The three new products received FDA clearance in 2013 and are:
Help employers find you! Check out all the jobs and post your resume.
